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HNMR and MS. present in several vitamins, coenzymes, nucleic acids etc. therefore Pyrimidines and their derivatives are considered to be important for drugs and agricultural chemicals 2, 3 . This ring system is incorporated into drugs is widely used as antiviral and for the treatment of AIDS, Cancer [4] [5] [6] [7] [8] [9] .
The synthesis of this series of heterocyclics was undertaken on this assumption that incorporation of one or more than one bioactive heterocyclic moiety into the pyrimidine framework may result heterocycles with enhanced biological activity.
Pyrimidine is a promising structural moiety (fig-4.1)for drug designing. Pyrimidine derivatives form a component in a number of useful drugs and are associated with many biological, pharmaceutical and therapeutically activities 15 
EXPERIMENTAL
Melting points were determined on an open capillary and are uncorrected. The IR spectra were recorded on Schimadzu FTIR-8400S. 1H NMR spectra were recorded in DMSO-d6 and CDCl3 on Brukar 500 spectrometer using TMS as reference, expressed in ´ ppm. and Mass spectra were taken on a Bosch Tech -X 600 mass spectrometer at 70 eV. A mixture of 4.078(0.513g,.001mol), thiourea(0.01g,0.0051mol) and 0.1g NaOH in 25ml of 80% dil.ethanol was refluxed for 1.5h, then concentrated and cooled, the precipitated 4.080a was filtered off and recrystallized from ethanol. To a mixture a thiourea (0.152g,0.002mol), sodium ethoxide(1.36g,0.02mol) and ethanol(25-30ml) was added 4.081a(1.058g,.002mol) and the reaction mixture was refluxed for 14 h. The solvent was removed by distillation and residue was treated with glacial acetic acid (7-10ml just enough to dissolved sodium salt of the pyrimidine) and refluxed for 15 minutes. The reaction mixture was acidified with AcOH and precipitate was collected and purified by crystallization with ethanol to give 4.083a 0.789g Yield 76% m.pt. 274-75 0 C.Similarly 4.083b, 4.083c, 4.084d were prepared from reaction of 4.081b on its reaction with thiourea and 4.081a, 4.081b on its reaction with urea respectively. To a solution of 4.084a (0.480g,1mmol) in ethanol (1000 ml) were added acetamidine hydrochloride (0. 5 -a m i n o -3 -m e r c a p t o -3 , 5 , 6 , 9 ,  10,11,12,15-octahydro-2H-[1,6 
10-benzyl-2-mercapto-4-phenyl-3,5,6,9, 10,11,12,15-octahydro-2H-[1,6]naphthyridino [3,2-h] pyrimido [4,5a]carbazole-8-carboxylicacid (4.080a).
The compound 4.080a was obtained by applying the general procedure mentioned above. -2-mercapto-3,5 ,6,9,10,11 
10-benzyl-4-ethoxy

RESULTS AND DISCUSSION
In the present work, the synthesis of incorporated six membered rings viz; hydroxyl pyrimidine, mercapto pyrimidine, amino pyrimidine, methyl pyrimidine on the carbazole and azacarbazole fused aza-acridine nucleus carried out by the cyclocondensation of corresponding enol ethers, chalcones, oxoketene dithioacetals, and dimethyl aminomethylene ketones with urea, thiourea, acetamide, and guanidine respectively. The enol ethers, chalcones, oxoketene dithioacetals, and dimethyl aminomethylene ketones were synthesized in accordance to the sequence of reaction shown under the heading of the synthesis of starting materials. When enol ethers (4.075a,b), were reacted with malononitrile in the presence of ammonium acetate 66 and the resulting o-amino pyridonitrile derivatives were treated with thiourea (4.076a) and urea (4.076b) ,formed the corresponding pyrimidine derivative 
CONCLUSION
In conclusion, an efficient methodology for the synthesis of pyrimido condensed oxocarbazoles and oxoazacarbazoles and their one-pot conversion to corresponding carbazolo and azacarbazolo fused quinoline carboxylic acids was developed. Heterocyclic scaffolds bearing these structures have been widely studied because of their impressive pharmacological activities. It was, therefore, reasoned that the presence of pyrimidine, carbazole or azacarbazole and quinoline carboxylic acid in tandem with the same molecular framework could produce the novel heterocyclic scaffolds with interesting biological activities
